Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory

It has been previously reported that active vitamin D3 (VD3) is a candidate drug that can repair alveolar damage in chronic obstructive pulmonary disease at a very low dose. We herein report the optimization of a very low-dose formulation of VD3 for dry powder inhalation by a simple method based on...

Full description

Bibliographic Details
Main Authors: Kahori Miyamoto, Misato Yanagisawa, Hiroaki Taga, Hiromichi Yamaji, Tomomi Akita, Chikamasa Yamashita
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/5/632
id doaj-5a7a5b3510c24ea29f4cebfda721da7b
record_format Article
spelling doaj-5a7a5b3510c24ea29f4cebfda721da7b2021-04-29T23:02:18ZengMDPI AGPharmaceutics1999-49232021-04-011363263210.3390/pharmaceutics13050632Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight TheoryKahori Miyamoto0Misato Yanagisawa1Hiroaki Taga2Hiromichi Yamaji3Tomomi Akita4Chikamasa Yamashita5Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, JapanDepartment of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, JapanDepartment of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, JapanDepartment of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, JapanDepartment of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, JapanDepartment of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, JapanIt has been previously reported that active vitamin D3 (VD3) is a candidate drug that can repair alveolar damage in chronic obstructive pulmonary disease at a very low dose. We herein report the optimization of a very low-dose formulation of VD3 for dry powder inhalation by a simple method based on time-of-flight (TOF) theory. As the preparation content of VD3 is very low, aerodynamic particle size distribution cannot be measured by pharmacopeial methods that require quantification of the main drug. Thus, a simple method based on TOF theory, which can measure aerodynamic particle size distribution without quantification, was used. The optimized formulation for an inhalation system using a lyophilized cake contained phenylalanine as the excipient (VD3 1 μg/vial + phenylalanine 0.3 mg/vial) and showed high performance with fine particle fraction ≤ 3 μm = 47.2 ± 4.4%. The difference between the results of pharmacopeial methods and simple method was examined using the formulation containing 10 µg/vial of VD3 and was within 5.0%. The preparation is expected to efficiently deliver VD3 to the lungs. Our simple method can optimize dry powder inhalation formulations more easily and rapidly even when the content of the main drug in a preparation is very low.https://www.mdpi.com/1999-4923/13/5/632vitamin D3dry powder inhalationpulmonary administrationtime-of-flight measurement
collection DOAJ
language English
format Article
sources DOAJ
author Kahori Miyamoto
Misato Yanagisawa
Hiroaki Taga
Hiromichi Yamaji
Tomomi Akita
Chikamasa Yamashita
spellingShingle Kahori Miyamoto
Misato Yanagisawa
Hiroaki Taga
Hiromichi Yamaji
Tomomi Akita
Chikamasa Yamashita
Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory
Pharmaceutics
vitamin D3
dry powder inhalation
pulmonary administration
time-of-flight measurement
author_facet Kahori Miyamoto
Misato Yanagisawa
Hiroaki Taga
Hiromichi Yamaji
Tomomi Akita
Chikamasa Yamashita
author_sort Kahori Miyamoto
title Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory
title_short Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory
title_full Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory
title_fullStr Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory
title_full_unstemmed Optimization of Very Low-Dose Formulation of Vitamin D3 with Lyophilizate for Dry Powder Inhalation System by Simple Method Based on Time-of-Flight Theory
title_sort optimization of very low-dose formulation of vitamin d3 with lyophilizate for dry powder inhalation system by simple method based on time-of-flight theory
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2021-04-01
description It has been previously reported that active vitamin D3 (VD3) is a candidate drug that can repair alveolar damage in chronic obstructive pulmonary disease at a very low dose. We herein report the optimization of a very low-dose formulation of VD3 for dry powder inhalation by a simple method based on time-of-flight (TOF) theory. As the preparation content of VD3 is very low, aerodynamic particle size distribution cannot be measured by pharmacopeial methods that require quantification of the main drug. Thus, a simple method based on TOF theory, which can measure aerodynamic particle size distribution without quantification, was used. The optimized formulation for an inhalation system using a lyophilized cake contained phenylalanine as the excipient (VD3 1 μg/vial + phenylalanine 0.3 mg/vial) and showed high performance with fine particle fraction ≤ 3 μm = 47.2 ± 4.4%. The difference between the results of pharmacopeial methods and simple method was examined using the formulation containing 10 µg/vial of VD3 and was within 5.0%. The preparation is expected to efficiently deliver VD3 to the lungs. Our simple method can optimize dry powder inhalation formulations more easily and rapidly even when the content of the main drug in a preparation is very low.
topic vitamin D3
dry powder inhalation
pulmonary administration
time-of-flight measurement
url https://www.mdpi.com/1999-4923/13/5/632
work_keys_str_mv AT kahorimiyamoto optimizationofverylowdoseformulationofvitamind3withlyophilizatefordrypowderinhalationsystembysimplemethodbasedontimeofflighttheory
AT misatoyanagisawa optimizationofverylowdoseformulationofvitamind3withlyophilizatefordrypowderinhalationsystembysimplemethodbasedontimeofflighttheory
AT hiroakitaga optimizationofverylowdoseformulationofvitamind3withlyophilizatefordrypowderinhalationsystembysimplemethodbasedontimeofflighttheory
AT hiromichiyamaji optimizationofverylowdoseformulationofvitamind3withlyophilizatefordrypowderinhalationsystembysimplemethodbasedontimeofflighttheory
AT tomomiakita optimizationofverylowdoseformulationofvitamind3withlyophilizatefordrypowderinhalationsystembysimplemethodbasedontimeofflighttheory
AT chikamasayamashita optimizationofverylowdoseformulationofvitamind3withlyophilizatefordrypowderinhalationsystembysimplemethodbasedontimeofflighttheory
_version_ 1721500191175999488